Skip directly to content

Annette Gaudino

New York, NY – July 27, 2018 – In major step forward, New York State Governor Andrew Cuomo delivered on his earlier commitment to eliminate hepatitis C virus (HCV) with today’s announcement of his intention to appoint a statewide Hepatitis C Elimination Task Force.

Countries and donors must do more to ensure all people with TB have access; further price reductions for newer medicines required

NEW YORK, NY – June 19, 2018 Treatment Action Group (TAG) welcomes the announcement  from the Stop TB Partnership’s Global Drug Facility (GDF) that new agreements have substantially lowered the price of medicines used to treat tuberculosis (TB).1 The GDF estimates that USD 31 million will be saved as a result.

These dramatic cost savings must be put into diagnosing and treating more patients, as the World Health Organization (WHO) estimates that only 26% of

Ending the Epidemic: Building Effective Collaboration between Community Advocates and Health Departments, presented by Treatment Action Group and Housing Works, May 31, 2018

Since 2014, community-led Ending the Epidemic (EtE) initiatives have advanced across the nation, setting ambitious targets to reduce HIV incidence below epidemic levels in states, counties, and cities in the US. Aligning the priorities of state and city health departments with the priorities of the communities they serve is an essential part of the EtE process.

View the final letter with all organization and individual sign ons

Dr. Josephine K. Olsen
Director, Peace Corps
1111 20th Street NW
Washington, DC 20526

Re: Peace Corps’ Policies and Practices with Respect to Volunteers Newly Diagnosed with HIV

Dear Dr. Olsen,

The undersigned individuals and organizations are writing to express our dismay at the recent dismissal of two Peace Corps volunteers shortly after they tested positive and initiated treatment for HIV. Current Peace Corps protocols appear to create de facto automatic dismissal for any newly diagnosed volunteer.

Affordable Medicines Now is a training conference designed to build skills, knowledge and community among the activists who power the movement for affordable medicines at the state, federal, and international levels.The conference is being organized by TAG in partnership with Public Citizen, the O'Neill Instute for National and Global Health Law at Georgetown University, and a number of other organizations working on drug pricing and access to medicines in the U.S.

At the conference, you will learn new skills for organizing at home, including:

  • How to use

In 2014, Governor Andrew Cuomo backed a community advocated plan to aggressively scale up testing, linkage to treatment, and PrEP access in order to dramatically reduce new infections below epidemic levels by the year 2020. The good news is that the recent release of the 2016 HIV/AIDS surveillance data shows that Ending the Epidemic (EtE) efforts in New York are having an impact. However, despite this success, challenges still remain–particularly for communities outside the New York City region.

On Friday, April 13th, TAG and Housing Works hosted a discussion with New York EtE leadership to

As unbelievable as it sounds in 2018, despite being preventable and curable Tuberculosis (TB) is on the rise in New York City for the first time in 25 years. Cases of drug-resistant TB, which are much more difficult and costly to treat, are increasing as well. This resurgence of TB is a direct result of years of underinvestment in New York's TB response.

TAG, along with many of our partners, are so alarmed by TB's recent rise—especially since it disproportionately affects the most vulnerable: people with weakened immune systems, people living in crowded environments, and immigrant


Download TAGline Fall 2018


Bringing Down the House on Intellectual Property and Access

As the Trump administration makes noise about  the high price of pharmaceuticals while doubling down on its commitment to “protect the engine of American ingenuity,” this issue of TAGline dives deep into the rhetoric and realities of intellectual property  (IP)  protections  and  the current wave of political shenanigans on critical drugs, surfacing the fundamental lies and vested interests that deny medication to those in need in the United

Spring 2018 TAGline

Incremental change—activism that successfully defends or advances critical research or policy—can sometimes feel inconsequential, particularly when it is hard won, resource intensive, and intangible. But in the context of public health strategies with ambitious targets and formidable stakeholder engagement, it is an undeniable facet of progress. In this issue of TAGline, we highlight some important recent successes and challenges in meeting TAG’s overarching goals: moving beyond achingly slow trends and sharply bending the curves on new HIV, hepatitis C, and tuberculosis infections, suffering,